The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
NeoGenomics Inc. | COM NEW | 64049M209 | 119,266 | 3,233,015 | SH | SOLE | 3,233,015 | 0 | 0 | ||
Horizon Therapeutics Public Limited Company | SHS | G46188101 | 33,205 | 427,465 | SH | SOLE | 427,465 | 0 | 0 | ||
Vericel Corporation | COM | 92346J108 | 21,323 | 1,150,735 | SH | SOLE | 1,150,735 | 0 | 0 | ||
Five9, Inc. | COM | 338307101 | 8,627 | 66,525 | SH | SOLE | 66,525 | 0 | 0 | ||
Intersect ENT Inc. | COM | 46071F103 | 1,266 | 77,630 | SH | SOLE | 77,630 | 0 | 0 | ||
ISHARES TR | CORE 1 5 YR USD | 46432F859 | 106 | 2,050 | SH | SOLE | 2,050 | 0 | 0 | ||
ISHARES TR | CORE S&P500 ETF | 464287200 | 98 | 292 | SH | SOLE | 292 | 0 | 0 | ||
ISHARES TR | CORE MSCI EAFE | 46432F842 | 71 | 1,178 | SH | SOLE | 1,178 | 0 | 0 | ||
ISHARES TR | CORE INTL AGGR | 46435G672 | 44 | 783 | SH | SOLE | 783 | 0 | 0 | ||
ISHARES TR | CR 5 10 YR ETF | 46435G417 | 40 | 764 | SH | SOLE | 764 | 0 | 0 | ||
ISHARES TR | CORE S&P MCP ETF | 464287507 | 27 | 147 | SH | SOLE | 147 | 0 | 0 | ||
ISHARES TR | CORE MSCI EMKT | 46434G103 | 17 | 316 | SH | SOLE | 316 | 0 | 0 | ||
ISHARES TR | CORE S&P SCP ETF | 464287804 | 15 | 207 | SH | SOLE | 207 | 0 | 0 |